GlassScriptPhysician profile
Richard L Moskowitz
NPI 1689649030
$696.92
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.65 · 2020: $44.95 · 2021: $81.91 · 2022: $52.31 · 2023: $120 · 2024: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $476.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $197.05 | 2022-2024 | Eea |
| Axonics, INC. | $171.58 | 2023-2024 | Axonics |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.68 | 2019-2023 | Plenvu, Xifaxan |
| Braintree Laboratories, INC. | $40.03 | 2021-2023 | Suflave |
| Exact Sciences Corporation | $27.52 | 2024 | Cologuard Collection Kit |
| Thd America, INC. | $19.74 | 2021 | |
| Guard Medical INC. | $16.96 | 2023 | Npseal Medium, Npseal Large, Npseal (5) |
| Vertex Pharmaceuticals Incorporated | $15.79 | 2024 | |
| Ferring Pharmaceuticals INC. | $15.59 | 2024 | Rebyota |
| Olympus America INC. | $15.49 | 2019 | |
| Eyepoint US, INC. | $15.00 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $13.98 | 2022 | |
| Zyla Life Sciences, INC. | $13.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Moskowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.